Pro: The Hepcon HMS Should Be Used Instead of Traditional Activated Clotting Time (ACT) to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass
Authors:
- 1 December 2016
- journal article
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 30 (6) , 1727-1729
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Anticoagulation monitoring during extracorporeal circulation with the Hepcon/HMS devicePerfusion, 2012
- Heparin monitoring during cardiac surgery. Part 1: validation of whole-blood heparin concentration and activated clotting timePerfusion, 2003
- Hemostatic Activation and Inflammatory Response during Cardiopulmonary BypassAnesthesiology, 2002
- Anticoagulation Monitoring during Cardiac SurgeryAnesthesiology, 1999
- Hemostasis Management by Use of Hepcon/HMS™: Increased Bleeding Without Increased Need for Blood TransfusionThe Thoracic and Cardiovascular Surgeon, 1999
- Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1999
- The activated coagulation time: Suitability for monitoring heparin effect and neutralization during pediatric cardiac surgeryJournal of Cardiothoracic and Vascular Anesthesia, 1996
- More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACTThrombosis and Haemostasis, 1996
- The impact of heparin concentration and activated clotting time monitoring on blood conservationThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operationsThe Journal of Thoracic and Cardiovascular Surgery, 1994